Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NPAS3 |
| Upstream (Parents) |
|---|
| (<<) ATP2B1 → NPAS3 |
| (<<) CABC1 → NPAS3 |
| (<<) CAMKK2 → NPAS3 |
| (<<) CDC42 → NPAS3 |
| (<<) CHAC1 → NPAS3 |
| (<<) CRNN → NPAS3 |
| (<<) CYP2U1 → NPAS3 |
| (<<) FUT1 → NPAS3 |
| (<<) GRB10 → NPAS3 |
| (<<) GRB2 → NPAS3 |
| (<<) GSK3B → NPAS3 |
| (<<) HSPA5 → NPAS3 |
| (<<) ITGA7 → NPAS3 |
| (<<) KHDRBS3 → NPAS3 |
| (<<) MRAS → NPAS3 |
| (<<) MYL7 → NPAS3 |
| (<<) PAK4 → NPAS3 |
| (<<) RARA → NPAS3 |
| (<<) STEAP1 → NPAS3 |
| (<<) TMEM39B → NPAS3 |
| (<<) WNT3 → NPAS3 |
| Downstream (Children) |
|---|
| NPAS3 → CBL (>>) |
| NPAS3 → CDK6 (>>) |
| NPAS3 → FOXB1 (>>) |
| NPAS3 → GRIN2D (>>) |
| NPAS3 → KRT16 (>>) |
| NPAS3 → ME1 (>>) |
